LAE-001
N/A
Report date: 2025/04/29 21:23:13
NME
Base Information
Drug NameLAE-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesLaekna Ltd
Inactive CompaniesNovartis Pharma AgLaekna Therapeutics Shanghai Co Ltd
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A